Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
作者信息
Breccia Massimo, Efficace Fabio, Alimena Giuliana
出版信息
Leuk Res. 2012 Jul;36(7):804-5. doi: 10.1016/j.leukres.2012.02.032. Epub 2012 Mar 27.